Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 0

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 0
---
As filed with the Securities and Exchange Commission on March 6, 2025 No. 333-284816 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Clearwater Analytics Holdings, Inc. (Exact name of registrant as specified in its charter)

| Delaware                        |     |                         7372 |     | 87-1043711            |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -Primary Standard Industrial 
   Classification Code Number |     | -I.R.S. Employer      
 Identification Number |

777 W. Main Street Suite 900 Boise, ID (208) 433-1200 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Alphonse Valbrune Chief Legal Officer 777 W. Main Street Suite 900 Boise, ID 83702 (208) 433-1200 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies of all communications, including communications sent to agent for service, should be sent to:

| Constantine N. Skarvelis, P.C. 
 Marshall P. Shaffer, P.C.      
 Ross M. Leff, P.C.             
 Christie W.S. Mok              
 Kirkland & Ellis LLP           
 601 Lexington Avenue           
 New York, NY 10022             
 (212) 446-4800                 |     | Matthew Campobasso     
 General Counsel        
 Enfusion, Inc.         
 125 South Clark Street 
 Suite 750              
 Chicago, IL 6063       
 (312) 253-9800         |     | Mark E. Thierfelder         
 Eric S. Siegel              
 Michael S. Darby            
 Sarah Kupferman             
 Dechert LLP                 
 1095 Avenue of the Americas 
 New York, NY 10036          
 (212) 698-3500              |     | Gregg L. Katz       
 Joshua M. Zachariah 
 James Ding          
 Goodwin Procter LLP 
 100 Northern Avenue 
 Boston, MA 02210    
 (617) 570-1000      |

Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after this registration statement is declared effective and upon the satisfaction or waiver of all other